Patents by Inventor Kallan Peters

Kallan Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11439590
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: September 13, 2022
    Assignees: NOVEL DRUG SOLUTIONS LLC, PYP CAR NORTHWEST, PA
    Inventors: Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Peters
  • Publication number: 20190111045
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: May 3, 2017
    Publication date: April 18, 2019
    Inventors: William Wiley, Richard Dilzer, Dennis Elias Saadeh, Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Kallan Peters
  • Publication number: 20160279055
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Inventors: Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Peters, Dennis Elias Saadeh
  • Publication number: 20150024996
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: March 27, 2014
    Publication date: January 22, 2015
    Applicant: IMPRIMIS PHARMACEUTICALS, INC.
    Inventors: Jeffrey T. LIEGNER, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Peters